Evidence map›Paper›PMID 24232379›Full record

ArticleEuropean journal of nutrition2014

Pomegranate and its derivatives can improve bone health through decreased inflammation and oxidative stress in an animal model of postmenopausal osteoporosis.

Mélanie Spilmont, Laurent Léotoing, Marie-Jeanne Davicco, Patrice Lebecque, Sylvie Mercier, Elisabeth Miot-Noirault, Paul Pilet, Laurent Rios, Yohann Wittrant, Véronique Coxam

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in European journal of nutrition, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 76 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Preventive Effects ofEvidence-based complementary and alternative medicine : eCAM · 2020
    Article
  19. Evidence-based complementary and alternative medicine : eCAM · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Mélanie Spilmont
Laurent Léotoing
Marie-Jeanne Davicco
Patrice Lebecque
Sylvie Mercier
Elisabeth Miot-Noirault
Paul Pilet
Laurent Rios
Yohann Wittrant
Véronique Coxam
Génétique, Diversité, Écophysiologie des Céréales · FRUnité de Nutrition Humaine · FRUniversité Clermont Auvergne · FRGreentech (France) · FRLe Laboratoire d'Ingénierie Ostéo-Articulaire et Dentaire · FRUniversity of Clermont Auvergne · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeRecently, nutritional and pharmaceutical benefits of pomegranate (PG) have raised a growing scientific interest. Since PG is endowed with anti-inflammatory and antioxidant activities, we hypothesized that it may have beneficial effects on osteoporosis.

methodsWe used ovariectomized (OVX) mice as a well-described model of postmenopausal osteoporosis to study the influence of PG consumption on bone health. Mice were divided into five groups as following: two control groups sham-operated and ovariectomized (OVX CT) mice fed a standard diet, versus three treated groups OVX mice given a modified diet from the AIN-93G diet, containing 5.7% of PG lyophilized mashed totum (OVX PGt), or 9.6% of PG fresh juice (OVX PGj) or 2.9% of PG lyophilized mashed peel (OVX PGp).

resultsAs expected, ovariectomy was associated with a decreased femoral bone mineral density (BMD) and impaired bone micro-architecture parameters. Consumption of PGj, PGp, or PGt induced bone-sparing effects in those OVX mice, both on femoral BMD and bone micro-architecture parameters. In addition, PG (whatever the part) up-regulated osteoblast activity and decreased the expression of osteoclast markers, when compared to what was observed in OVX CT animals. Consistent with the data related to bone parameters, PG consumption elicited a lower expression of pro-inflammatory makers and of enzymes involved in ROS generation, whereas the expression of anti-inflammatory markers and anti-oxidant actors was enhanced.

conclusionThese results indicate that all PG parts are effective in preventing the development of bone loss induced by ovariectomy in mice. Such an effect could be partially explained by an improved inflammatory and oxidative status.

Indexed as

AnimalsAnti-Inflammatory AgentsAntioxidantsBone and BonesBone DensityDisease Models, AnimalFemaleInflammationLythraceaeMiceMice, Inbred C57BLOsteoporosisOvariectomyOxidative StressPhytotherapyPlant PreparationsAnti-Inflammatory AgentsAntioxidantsPlant Preparations

Identifiers

PMID24232379
OpenAlexW2108357988

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.